UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Date of Report (Date of earliest event reported) June 29, 2005


                            Interpharm Holdings, Inc.
                            -------------------------

               (Exact name of Registrant as specified in charter)

          Delaware                     0-22710                   13-3673965
--------------------------------------------------------------------------------
(State or other jurisdiction         (Commission               (IRS Employer
    of incorporation)                 File Number)           Identification No.)


              75 Adams Avenue Hauppauge, New York               11788
             ---------------------------------------------------------
              (Address  of  principal executive offices)     (Zip Code)

Registrant's telephone number, including area code: (631) 952-0214

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:

|_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)

|_| Soliciting  material  pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)

|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR240.14d-2(b))

|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))

<PAGE>

Item 8.01         Other Events
---------         ------------

      On June 29, 2005,  Surinder  Rametra,  an employee  the  Company,  sold in
private  transactions at a price of $1.28 per share,  175,000 and 150,000 shares
of the Company's  restricted Common Stock to the Julianna Nicole Reid Trust (the
"Trust") and Amit Rametra,  respectively. The Trust was created by Cameron Reid,
the Chief  Executive  Officer of the Company,  for the benefit of certain of his
family members. Amit Rametra is Surinder Rametra's son.


                                   Signatures
                                   ----------

      Pursuant to the  requirements of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                   INTERPHARM HOLDINGS, INC.

July 1, 2005                       By: /s/George Aronson
                                      ---------------------
                                       George Aronson
                                       Chief Financial Officer
{"company-data": {"conformed-name": "INTERPHARM HOLDINGS INC", "cik": "0000893970", "assigned-sic": "2834", "irs-number": "133673965", "state-of-incorporation": "DE", "fiscal-year-end": "0630"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-15981", "film-number": "05932786"}, "business-address": {"street1": "75 ADAMS AVENUE", "city": "HAUPPAGUE", "state": "NY", "zip": "11788", "phone": "6319520214"}, "former-company": [{"former-conformed-name": "ATEC GROUP INC", "date-changed": "19951221"}, {"former-conformed-name": "HILLSIDE BEDDING INC", "date-changed": "19940719"}, {"former-conformed-name": "NATIONAL HILLSIDE BEDDING CORP", "date-changed": "19930115"}]}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) June 29, 2005

                            Interpharm Holdings, Inc.
                            -------------------------

               (Exact name of Registrant as specified in charter)

          Delaware                     0-22710                   13-3673965
--------------------------------------------------------------------------------
(State or other jurisdiction         (Commission               (IRS Employer
    of incorporation)                 File Number)           Identification No.)

              75 Adams Avenue Hauppauge, New York               11788
             ---------------------------------------------------------
              (Address  of  principal executive offices)     (Zip Code)

Registrant's telephone number, including area code: (631) 952-0214

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:

|_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)

|_| Soliciting  material  pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)

|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR240.14d-2(b))

|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
Item 8.01         Other Events
---------         ------------

      On June 29, 2005,  Surinder  Rametra,  an employee  the  Company,  sold in
private  transactions at a price of $1.28 per share,  175,000 and 150,000 shares
of the Company's  restricted Common Stock to the Julianna Nicole Reid Trust (the
"Trust") and Amit Rametra,  respectively. The Trust was created by Cameron Reid,
the Chief  Executive  Officer of the Company,  for the benefit of certain of his
family members. Amit Rametra is Surinder Rametra's son.

                                   Signatures
                                   ----------

      Pursuant to the  requirements of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                   INTERPHARM HOLDINGS, INC.

July 1, 2005                       By: /s/George Aronson
                                      ---------------------
                                       George Aronson
                                       Chief Financial Officer